DAWES KAREN A — SEC insider filings

SEC reporting owner CIK 1261506. 28 insider filings on record with FilingPulse; latest filed 2026-09-09.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2021-05-04 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REPLIGEN CORP (RGEN)Director22—58 legs · 55,397 sh · $12,238,69228
Barinthus Biotherapeutics plc. (BRNS)Director61 leg · 1,700 sh · $28,900—10

Insider filings — DAWES KAREN A

FiledFormIssuerReported transactionsSource
2026-09-094Barinthus Biotherapeutics plc. (BRNS)Disposition to issuer (D): 1,700 · Disposition to issuer (D): 34,328 (derivative) @ $0 · Disposition to issuer (D): 18,604 (derivative) @ $0 · Disposition to issuer (D): 19,197 (derivative) @ $0 · Disposition to issuer (D): 19,516 (derivative) @ $0 · Disposition to issuer (D): 20,174 (derivative) @ $0EDGAR
2026-05-184REPLIGEN CORP (RGEN)Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0EDGAR
2025-12-184REPLIGEN CORP (RGEN)Sale (S): 275 @ $161EDGAR
2025-06-114Barinthus Biotherapeutics plc. (BRNS)Grant/award (A): 20,174 (derivative) @ $0EDGAR
2025-05-194REPLIGEN CORP (RGEN)Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0EDGAR
2024-08-194/AREPLIGEN CORP (RGEN)Holdings only — no transactions reportedEDGAR
2024-06-144REPLIGEN CORP (RGEN)Option exercise (M): 2,953 @ $67.71 · Option exercise (M): 2,953 (derivative) @ $0EDGAR
2024-05-204REPLIGEN CORP (RGEN)Grant/award (A): 803 @ $0 · Grant/award (A): 1,576 (derivative) @ $0EDGAR
2024-05-144Barinthus Biotherapeutics plc. (BRNS)Grant/award (A): 19,516 (derivative) @ $0EDGAR
2024-02-284REPLIGEN CORP (RGEN)Option exercise (M): 4,626 @ $42.07 · Sale (S): 1,000 @ $193.35 · Option exercise (M): 4,626 (derivative) @ $0EDGAR
2023-08-304REPLIGEN CORP (RGEN)Option exercise (M): 7,392 @ $18.12 · Sale (S): 850 @ $171.38 · Option exercise (M): 7,392 (derivative) @ $0EDGAR
2023-05-224REPLIGEN CORP (RGEN)Grant/award (A): 798 @ $0 · Grant/award (A): 1,730 (derivative) @ $0EDGAR
2023-05-124Vaccitech plc (VACC)Grant/award (A): 19,197 (derivative) @ $0EDGAR
2022-09-094REPLIGEN CORP (RGEN)Sale (S): 775 @ $227.17EDGAR
2022-05-314REPLIGEN CORP (RGEN)Grant/award (A): 644 @ $0 · Grant/award (A): 1,565 (derivative) @ $0EDGAR
2022-05-264REPLIGEN CORP (RGEN)Sale (S): 2,576 @ $149.18 · Sale (S): 7,677 @ $150.19 · Sale (S): 1,845 @ $151.14 · Sale (S): 1,875 @ $152.14 · Sale (S): 742 @ $152.84EDGAR
2021-11-124REPLIGEN CORP (RGEN)Option exercise (M): 4,783 @ $26.12 · Sale (S): 462 @ $259.75 · Sale (S): 236 @ $261.10 · Sale (S): 1,038 @ $262.28 · Sale (S): 1,119 @ $263.23 · Sale (S): 336 @ $264.21 · +6 moreEDGAR
2021-11-044REPLIGEN CORP (RGEN)Sale (S): 64 @ $299.02 · Sale (S): 251 @ $301.20 · Sale (S): 446 @ $301.97 · Sale (S): 532 @ $303.48 · Sale (S): 124 @ $304.23 · Sale (S): 700 @ $305.91 · +1 moreEDGAR
2021-09-154REPLIGEN CORP (RGEN)Sale (S): 13 @ $290.02 · Sale (S): 25 @ $292.34 · Sale (S): 101 @ $294.06 · Sale (S): 108 @ $295.02 · Sale (S): 27 @ $295.82EDGAR
2021-09-024REPLIGEN CORP (RGEN)Option exercise (M): 3,459 @ $38.76 · Sale (S): 239 @ $280.27 · Sale (S): 196 @ $281.68 · Sale (S): 405 @ $282.53 · Sale (S): 661 @ $283.56 · Sale (S): 1,107 @ $284.64 · +2 moreEDGAR
2021-08-194REPLIGEN CORP (RGEN)Sale (S): 924 @ $251.15 · Sale (S): 920 @ $251.92 · Sale (S): 4,665 @ $253.34 · Sale (S): 8,580 @ $254.09 · Sale (S): 2,231 @ $255.07 · Sale (S): 194 @ $256.43 · +5 moreEDGAR
2021-07-224/AREPLIGEN CORP (RGEN)Option exercise (M): 2,929 @ $41.19 · Sale (S): 441 @ $201.27 · Sale (S): 630 @ $202.29 · Sale (S): 444 @ $203.09 · Sale (S): 5 @ $204.02 · Option exercise (M): 2,929 (derivative) @ $0EDGAR
2021-07-224REPLIGEN CORP (RGEN)Sale (S): 288 @ $200.01 · Sale (S): 806 @ $201.37 · Sale (S): 2,877 @ $202.29 · Sale (S): 614 @ $203.11EDGAR
2021-07-154REPLIGEN CORP (RGEN)Option exercise (M): 2,929 @ $41.19 · Sale (S): 1,520 @ $202.23 · Option exercise (M): 2,929 (derivative) @ $0EDGAR
2021-05-174REPLIGEN CORP (RGEN)Grant/award (A): 604 @ $0 · Grant/award (A): 1,522 (derivative) @ $0EDGAR
2021-05-134REPLIGEN CORP (RGEN)Option exercise (M): 15,000 @ $3.22 · Sale (S): 285 @ $176.85 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-05-064Vaccitech plc (VACC)Purchase (P): 1,700 @ $17EDGAR
2021-05-044Vaccitech plc (VACC)Grant/award (A): 34,328 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1261506 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs